Calgary, Alberta – TheNewswire - August 26, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce that it has completed the one-week postoperative examination of the first patients who were implanted with the Ocumetics Accommodating Intraocular Lens (the “Ocumetics Lens”).  All patients are recovering well, and no complications have been observed.  With this important milestone achieved, a ...